• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clinical characterization of influenza A and human respiratory syncytial virus among patients with influenza like illness

tetano

Editor, Senior Moderator
J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24607. [Epub ahead of print]
[h=1]Clinical characterization of influenza A and human respiratory syncytial virus among patients with influenza like illness.[/h] Saxena S[SUP]1,[/SUP][SUP]2[/SUP], Singh D[SUP]1[/SUP], Zia A[SUP]1[/SUP], Umrao J[SUP]1[/SUP], Srivastava N[SUP]1[/SUP], Pandey A[SUP]1[/SUP], Singh S[SUP]1[/SUP], Bhattacharya P[SUP]1[/SUP], Kumari R[SUP]2[/SUP], Kushwaha R[SUP]2[/SUP], Dhole TN[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza A and Respiratory Syncytial Virus (RSV) has been recognized as a major cause of acute respiratory tract infection. H1N1 is one of the subtypes of influenza A, pandemic worldwide in July2009, causing 18,449 deaths globally.
[h=4]OBJECTIVES:[/h] To investigate the prevalence and clinical manifestation of the influenza A, H1N1pdm09 and RSV.
[h=4]METHOD:[/h] Throat/nasal swab collected from the patients of all age group either outpatients/inpatients having respiratory illness from 2 to 5 days. The clinical data were recorded in a predesigned questionnaire. RNA was extracted and analyzed by real time PCR at a tertiary care center, 2009-2014.
[h=4]RESULTS:[/h] Total 4352 samples tested for influenza A and H1N1. Out of 4352, 32.2% (median positivity 21%; range 16-41% during six years) were positive for influenza A and 19% were H1N1 (median positivity 16.7%; range 8.7-23% during six years). Total 1653 samples were analyzed for RSV from 2011-2014, 12% were RSV positive (median positivity11.35%; range 10-16.3% during four years). Pharyngitis, dyspnea were frequent symptoms in influenza A and H1N1 (p < 0.005) whereas bronchiolitis and pneumonia were commonly present in RSV (p < 0.005). The positivity of influenza A and H1N1 was higher in age-group 21-30, whereas RSV in infant and children.
[h=4]CONCLUSION:[/h] H1N1and RSV were co-circulated and have common clinical symptoms particularly in lower age group. Therefore, laboratory confirmation is necessary for further disease prognosis. Age was an important risk factor that affects the positivity of influenza A, H1N1 and RSV. Different clinical manifestation of H1N1 and RSV will be helpful for early and accurate diagnosis. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] Epidemiology; Influenza virus; Respiratory tract infection

PMID: 27329816 [PubMed - as supplied by publisher]
 
Back
Top Bottom